APOD and Alzheimer disease: Overall, the data show that the neuroprotective apoD is increased in AD brain tissue but not in FTLD, suggesting significantly different reactions to oxidative stress in these two forms of dementia—the apoD response in AD appears to be somewhat neuroprotective, while its unchanging level in FTLD may exacerbate the neurodegeneration.